4.5 Article

Melittin as a safe compound to BALB/c mice immune system; a tiered approach immunotoxicity screening

Journal

BMC COMPLEMENTARY MEDICINE AND THERAPIES
Volume 23, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12906-023-04228-w

Keywords

Melittin; Immune system; Humoral immunity; Cellular immunity

Ask authors/readers for more resources

Our study showed that melittin had no significant pathological effects on the spleen and bone marrow, as well as no impact on hematological parameters. Additionally, melittin did not affect proliferation response of splenocytes, spleen cellularity, DTH response, and the production of anti-SRBC antibodies in the mice immune system.
BackgroundMaintenance of immune system integrity is a vital requirement to protect human body against pathogens/cancers. Natural compounds have long been used due to their benefits for the immune system. One of which is bee venom that contains a peptide called melittin having antimicrobial and anticancer effects. Since a limited number of studies regarding the effects of melittin on the immune system have been carried out, we aimed to evaluate the effects of melittin on BALB/c mice immune system parameters.MethodsFemale BALB /c mice were treated intraperitoneally (i.p) with 0.75 and 1.5 mg/kg doses of melittin for 14 days (5 doses per week). The negative control group received i.p normal saline whereas the positive controls received i.p 20 mg/kg cyclophosphamide (CYP). Immunological parameters such as hematological parameters, delayed-type hypersensitivity (DTH), hemagglutination titer (HA), spleen cellularity, splenocytes proliferation, as well as spleen and bone marrow histopathological assessment were evaluated.ResultsOur findings showed that melittin has no gross pathological effect on the spleen and bone marrow. It was also demonstrated that melittin has no any significant effect on hematological parameters. Melittin did not cause any significant changes to proliferation response of splenocytes to PHA and LPS, spleen cellularity, DTH response, as well as the production of anti-SRBC antibodies. According to our results, melittin at 0.75 and 1.5 mg/kg doses could not induce significant changes on immune parameters and as a result, melittin was found to be safe for the mice immune system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available